

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks


UK Shareholder Meetings Calendar - Next 7 Days


(Sharecast News) - Venture capital company Arix Bioscience noted on Wednesday that its portfolio company, Amplyx Pharmaceuticals, has closed a $53m (&...


Arix Bioscience Notes First Patient Dosed In Harpoon's HPN217 Trial


Syncona, Arix Note US FDA Acceptance Of Autolus Drug Application


UK EXECUTIVE CHANGE SUMMARY: Two Co-Founders Leave Arix Bioscience


Arix Biosciences Invests Further Into Imara Following US IPO Pricing


(Sharecast News) - Biotechnology venture capital company Arix Bioscience reported a year-end net asset value of ?202m in its annual results on Tuesday...